| Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression N Bobrovitz, H Ware, X Ma, Z Li, R Hosseini, C Cao, A Selemon, ... The Lancet Infectious Diseases 23 (5), 556-567, 2023 | 369 | 2023 |
| Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies I Bergeri, MG Whelan, H Ware, L Subissi, A Nardone, HC Lewis, Z Li, ... PLoS medicine 19 (11), e1004107, 2022 | 134 | 2022 |
| SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021 HC Lewis, H Ware, M Whelan, L Subissi, Z Li, X Ma, A Nardone, ... BMJ Global Health 7 (8), e008793, 2022 | 118 | 2022 |
| Global epidemiology of SARS-CoV-2 infection: a systematic review and meta-analysis of standardized population-based seroprevalence studies, Jan 2020-Oct 2021 I Bergeri, M Whelan, H Ware, L Subissi, A Nardone, HC Lewis, Z Li, X Ma, ... MedRxiv, 2021 | 49 | 2021 |
| Protective effectiveness of prior SARS-CoV-2 infection and hybrid immunity against Omicron infection and severe disease: a systematic review and meta-regression N Bobrovitz, H Ware, X Ma, Z Li, R Hosseini, C Cao, A Selemon, ... MedRxiv, 2022.10. 02.22280610, 2022 | 22 | 2022 |
| Unity Studies Collaborator Group. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies I Bergeri, MG Whelan, H Ware, L Subissi, A Nardone, HC Lewis, Z Li, ... PLoS Med 19 (11), e1004107, 2022 | 20 | 2022 |
| Global SARS-CoV-2 seroprevalence: a systematic review and meta-analysis of standardized population-based studies from Jan 2020-May 2022 I Bergeri, M Whelan, H Ware, L Subissi, A Nardone, HC Lewis, Z Li, X Ma, ... medRxiv, 2021.12. 14.21267791, 2021 | 15 | 2021 |
| Prompting is all you need: LLMs for systematic review screening C Cao, J Sang, R Arora, R Kloosterman, M Cecere, J Gorla, R Saleh, ... medRxiv, 2024.06. 01.24308323, 2024 | | 2024 |
| Adherence of SARS-CoV-2 seroepidemiologic studies to the ROSES-S reporting guideline during the COVID-19 pandemic B Cheng, E Loeschnik, A Selemon, R Hosseini, J Yuan, H Ware, X Ma, ... medRxiv, 2023.06. 02.23290895, 2023 | | 2023 |
